Evidence map›Paper›PMID 36557569›Full record

ReviewMicroorganisms2022

An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics.

Dàmaris Berbel, Aida González-Díaz, Guillem López de Egea, Jordi Càmara, Carmen Ardanuy

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Reporting macrolide-resistantJournal of clinical microbiology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. One health (Amsterdam, Netherlands) · 2025
    Review
  18. Increase of macrolide resistance amongAntimicrobial agents and chemotherapy · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dàmaris BerbelMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, 08907 Barcelona, Spain.ORCID 0000-0002-3689-3360
Aida González-DíazMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, 08907 Barcelona, Spain.
Guillem López de EgeaMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, 08907 Barcelona, Spain.ORCID 0000-0002-4196-7627
Jordi CàmaraMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, 08907 Barcelona, Spain.ORCID 0000-0002-0817-0931
Carmen ArdanuyMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL-UB, 08907 Barcelona, Spain.ORCID 0000-0003-0225-607X
Instituto de Salud Carlos III · ES

Funding

CIBER de Enfermedades Respiratorias, CIBERES CB06/06/0037Fondo de Investigaciones Sanitarias de la Seguridad Social PI18/00339Fondo de Investigaciones Sanitarias de la Seguridad Social PI21/01000
6 · The paper itself

Abstract

Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the main alternatives. This work focuses on studying macrolide resistance rates, genetic associated determinants and antibiotic consumption data in Spain, Europe and also on a global scale. Macrolide resistance (MR) determinants, such as ribosomal methylases (

Indexed as

GASICEIMEmacrolide resistancemobile genetic elementspneumococcusStreptococcusStreptococcus pneumoniaeStreptococcus pyogenes

Identifiers

PMID36557569
PMCPMC9783990
OpenAlexW4309728393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.